In Veritas Price To Sales Ratio Over Time

IVME Stock  USD 0.0001  0.00  0.00%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out In Veritas Performance and In Veritas Correlation.
  
As of December 19, 2024, Price To Sales Ratio is expected to decline to 6.63.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In Veritas. If investors know IVME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In Veritas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(6.48)
The market value of In Veritas Medical is measured differently than its book value, which is the value of IVME that is recorded on the company's balance sheet. Investors also form their own opinion of In Veritas' value that differs from its market value or its book value, called intrinsic value, which is In Veritas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In Veritas' market value can be influenced by many factors that don't directly affect In Veritas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In Veritas' value and its price as these two are different measures arrived at by different means. Investors typically determine if In Veritas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In Veritas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Price To Sales Ratio Analysis

Compare In Veritas Medical and related stocks such as Eldorado Gold Corp, Griffon, and Sphere Entertainment Price To Sales Ratio Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
Capex To RevenuePocfratio
Interest CoverageCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Income QualityRoe
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Current RatioReceivables Turnover
Debt To EquityRevenue Per Share
Debt To AssetsDividend Yield
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesFree Cash Flow Per Share
Average InventoryCash Per Share
Payout RatioNet Current Asset Value
Tangible Asset ValueNet Debt To E B I T D A
Tangible Book Value Per ShareGraham Number
Shareholders Equity Per ShareCapex Per Share
Graham Net NetAverage Receivables
Interest Debt Per ShareEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityDividend Payout Ratio
Enterprise Value MultipleOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
EGO(1.844)6.8597.73343.62054.07812.46535.33232.76910.99452.07112.21081.78681.75982.50072.38
GFF0.24580.28870.33880.26220.32420.33180.55470.29770.36110.32120.51170.53550.76991.26931.33
SPHR0.90730.90730.90730.90730.90730.90731.36650.99170.9350.57892.04141.36451.6541.19010.98
MTX1.18290.97451.40132.04661.3890.88531.64591.44631.00261.12621.33211.32260.93421.06811.43
ZDGE6.41046.41046.41046.41044.62373.04161.95362.67821.84141.633110.32631.57021.08671.69531.61
AVNT0.40420.37190.6080.89520.91230.82560.80491.09760.64510.99211.11941.06120.90641.2051.27

In Veritas Medical and related stocks such as Eldorado Gold Corp, Griffon, and Sphere Entertainment Price To Sales Ratio description

Price to Sales Ratio is figured by comparing In Veritas Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on In Veritas sales, a figure that is much harder to manipulate than other In Veritas Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

My Equities

My Current Equities and Potential Positions

In Veritas Medical
IVME
Specialization
Financial Services, Financial Services
Business AddressThe Green House,
ExchangeOTCCE Exchange
USD 1.0E-4
When determining whether In Veritas Medical is a strong investment it is important to analyze In Veritas' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact In Veritas' future performance. For an informed investment choice regarding IVME Stock, refer to the following important reports:
Check out In Veritas Performance and In Veritas Correlation.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
In Veritas technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of In Veritas technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of In Veritas trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...